Crowdsourcing post-marketing safety surveillance for migraine preventives: Self-reported adverse events associated with calcitonin gene-related peptide (CGRP) therapeutics on a social media forum

被引：0

|

作者：

Zhang, P. ^{[1
]}

Kamitaki, B. ^{[1
]}

Do, T. ^{[2
]}

机构：

[1] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA

[2] Rigshosp Glostrup, Neurol, Copenhagen, Denmark

来源：

CEPHALALGIA | 2021年 / 41卷 / 1_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P0342

引用

收藏

页码：183 / 183

页数：1

相关论文

共 4 条

[1] Crowdsourcing post-marketing safety surveillance for migraine preventives: Self-reported adverse events associated with calcitonin gene-related peptide (CGRP) therapeutics on a social media forum
Zhang, P.
Kamitaki, B.
Do, T.
HEADACHE, 2021, 61 : 92 - 93
[2] Crowdsourcing post-marketing safety surveillance for migraine preventives: Self-reported adverse events associated with calcitonin gene-related peptide (CGRP) therapeutics on a social media forum
Zhang, P.
Kamitaki, B.
Do, T.
JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 123 - 123
[3] Post-Marketing Safety of Anti-Calcitonin Gene Related Peptide Antibodies: A Disproportionality Analysis of the FDA Adverse Event Reporting System
Giunchi, V.
Fusaroli, M.
Antonazzo, I. C.
Hyeraci, G.
Raschi, E.
Poluzzi, E.
Mazzaglia, G.
Roberto, G.
DRUG SAFETY, 2022, 45 (10) : 1245 - 1245
[4] Impact of US Physicians' Perceptions of the Distinct Pharmacological and Clinical Characteristics of the Novel Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies on Self-Reported Chronic Migraine Prevention Brand Share
Schobel, V. R.
Robinson, J.
HEADACHE, 2019, 59 : 39 - 39